MJS BioLynx - Protein Biotechnologies

	Supplier of human clinical specimen derivatives and high-throughput protein and tissue microarrays.
	With the largest collection of ready-to-use, clinically defined, pathology-validated human specimen derivatives on the market, Protein Biotechnologies facilitates biomedical research and drug discovery efforts for cancer, neurodegenerative diseases, cardiovascular diseases, diabetes / obesity and autoimmune disease research.